Michael Bonner

Insider Reports History

Entity
Individual
Location
2525 West End Avenue, Suite 950, Nashville, TN
Signature
Michael Bonner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Bonner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CUMBERLAND PHARMACEUTICALS INC Chief Financial Officer Common Stock 11.7K $19.9K $1.70 May 17, 2021 Direct
CUMBERLAND PHARMACEUTICALS INC Chief Financial Officer Options (right to buy) 0 May 17, 2021 Direct

Insider Reports Filed by Michael Bonner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CPIX CUMBERLAND PHARMACEUTICALS INC Mar 17, 2021 4 -$24.7K 4 Jun 11, 2021 Chief Financial Officer